CN101857601B - 一种高纯度的拉氧头孢钠化合物 - Google Patents
一种高纯度的拉氧头孢钠化合物 Download PDFInfo
- Publication number
- CN101857601B CN101857601B CN2010101996929A CN201010199692A CN101857601B CN 101857601 B CN101857601 B CN 101857601B CN 2010101996929 A CN2010101996929 A CN 2010101996929A CN 201010199692 A CN201010199692 A CN 201010199692A CN 101857601 B CN101857601 B CN 101857601B
- Authority
- CN
- China
- Prior art keywords
- acid
- latamoxef
- value
- sodium
- latamoxef sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960000433 latamoxef Drugs 0.000 title claims abstract description 56
- GRIXGZQULWMCLU-HUTAOCTPSA-L disodium;(6r,7r)-7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].N([C@]1(OC)C(N2C(=C(CSC=3N(N=NN=3)C)CO[C@@H]21)C([O-])=O)=O)C(=O)C(C([O-])=O)C1=CC=C(O)C=C1 GRIXGZQULWMCLU-HUTAOCTPSA-L 0.000 title claims abstract 6
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000000746 purification Methods 0.000 claims abstract description 18
- 239000003513 alkali Substances 0.000 claims abstract description 10
- JWCSIUVGFCSJCK-CAVRMKNVSA-N Disodium Moxalactam Chemical compound N([C@]1(OC)C(N2C(=C(CSC=3N(N=NN=3)C)CO[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C1=CC=C(O)C=C1 JWCSIUVGFCSJCK-CAVRMKNVSA-N 0.000 claims description 50
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 238000010521 absorption reaction Methods 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 239000003610 charcoal Substances 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 2
- 125000001033 ether group Chemical group 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 229940071870 hydroiodic acid Drugs 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 14
- 238000001035 drying Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000005261 decarburization Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000010669 acid-base reaction Methods 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 0 C*1N=NN=C1SCC(COC1C2(NC(C(C(*)=O)C(CC3)=CC=C3O)=O)OC)=C(C(*)O)N1C2=O Chemical compound C*1N=NN=C1SCC(COC1C2(NC(C(C(*)=O)C(CC3)=CC=C3O)=O)OC)=C(C(*)O)N1C2=O 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- AYDQIZKZTQHYIY-UHFFFAOYSA-N OC(=O)C1(C)CC(C(O)=O)=CC=C1 Chemical compound OC(=O)C1(C)CC(C(O)=O)=CC=C1 AYDQIZKZTQHYIY-UHFFFAOYSA-N 0.000 description 1
- ODFJOVXVLFUVNQ-UHFFFAOYSA-N acetarsol Chemical compound CC(=O)NC1=CC([As](O)(O)=O)=CC=C1O ODFJOVXVLFUVNQ-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101996929A CN101857601B (zh) | 2010-06-13 | 2010-06-13 | 一种高纯度的拉氧头孢钠化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101996929A CN101857601B (zh) | 2010-06-13 | 2010-06-13 | 一种高纯度的拉氧头孢钠化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101857601A CN101857601A (zh) | 2010-10-13 |
CN101857601B true CN101857601B (zh) | 2012-11-21 |
Family
ID=42943787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101996929A Expired - Fee Related CN101857601B (zh) | 2010-06-13 | 2010-06-13 | 一种高纯度的拉氧头孢钠化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101857601B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104497011B (zh) * | 2015-01-14 | 2016-03-02 | 芦红代 | 一种拉氧头孢钠的制备方法 |
CN105037394B (zh) * | 2015-08-07 | 2017-07-04 | 浙江新和成股份有限公司 | 高纯度拉氧头孢钠的制备方法 |
CN105399754B (zh) * | 2015-12-17 | 2018-05-15 | 苏州中联化学制药有限公司 | 一种头孢孟多酯钠的制备方法 |
CN113072567B (zh) * | 2021-03-26 | 2022-10-14 | 海南海灵化学制药有限公司 | 一种拉氧头孢钠合成工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2153823B (en) * | 1984-02-02 | 1987-10-21 | Shionogi & Co | Purification of cephalosporins |
-
2010
- 2010-06-13 CN CN2010101996929A patent/CN101857601B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2153823B (en) * | 1984-02-02 | 1987-10-21 | Shionogi & Co | Purification of cephalosporins |
Also Published As
Publication number | Publication date |
---|---|
CN101857601A (zh) | 2010-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103450225B (zh) | 头孢西丁钠的制备方法 | |
CN101857601B (zh) | 一种高纯度的拉氧头孢钠化合物 | |
CN102391289A (zh) | 头孢他啶中间体及头孢他啶的合成方法 | |
CN101544660A (zh) | 一种头孢克肟化合物及其制法 | |
CN101619069A (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
CN105131017A (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN101787036B (zh) | 一种高纯度的头孢孟多酯钠化合物 | |
CN101798314B (zh) | 一种盐酸头孢甲肟化合物的精制方法 | |
CN103102357B (zh) | 一种头孢呋辛钠的合成方法 | |
CN101941983B (zh) | 一种高纯度头孢西丁钠的制备方法 | |
CN102731529A (zh) | 一种头孢克肟的精制方法 | |
CN101787039B (zh) | 一种高纯度的头孢美唑钠化合物 | |
CN101781264B (zh) | 1-甲基-5-巯基-1,2,3,4-四氮唑的生产方法 | |
CN101550147B (zh) | 一种头孢地尼化合物及其制法 | |
CN101550146A (zh) | 一种盐酸头孢他美酯化合物及其制法 | |
CN101654458A (zh) | 一种盐酸头孢噻呋的制备方法 | |
CN101798312B (zh) | 一种制备头孢丙烯化合物的方法 | |
CN103275103A (zh) | 一种制备硫酸头孢喹肟的方法 | |
CN108586491B (zh) | 一种盐酸头孢他美酯的制备方法 | |
CN101550152B (zh) | 一种头孢克洛化合物及其制法 | |
CN101787037A (zh) | 一种高纯度的盐酸头孢替安化合物 | |
CN102267953B (zh) | 合成头孢拉定或Cefroxadine的中间体化合物及其制备方法和应用 | |
CN102030763B (zh) | 一种头孢呋辛酯化合物及其新制法 | |
CN102127134B (zh) | 一种利巴韦林化合物及其方法 | |
CN101891755B (zh) | 一种头孢磺啶钠化合物及其新制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HU JIANRONG Effective date: 20130724 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130724 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Hu Jianrong |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121121 Termination date: 20160613 |
|
CF01 | Termination of patent right due to non-payment of annual fee |